Clinical Trials Browser

Phase 2 × Diarrhea × 1 year × Clear all

Diarrhea, Exanthema

NCT03767257 2025-10-21

A Study of Colesevelam for Lenalidomide-Associated Diarrhea

Phase 2 Completed

25 enrolled 6 charts

Plasma cell

Diarrhea, Multiple Myeloma

NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Phase 2 Completed

43 enrolled 23 charts

GastrointestinalOtherPlasma cell

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

Clinical Trials

SAFE-CAP

A Study of Colesevelam for Lenalidomide-Associated Diarrhea

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis